About Us

Acclarent, Inc. is a privately held medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients.

Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplasty™ devices. Through the Balloon Sinuplasty™ technology and our Relieva® product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year.

Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.

Overview of Sinusitis
Sinusitis affects 37 million people each year,^1,2,3 making it one of the most common health problems in the U.S. It is more prevalent than heart disease and asthma¹ and has a greater impact on quality of life than chronic back pain or congestive heart failure.⁴ Sinusitis is also responsible for $8 billion*⁵ in direct healthcare expenditures and a significant loss of workplace productivity.⁵

The most frequently used treatments for chronic sinusitis are medical therapies and / or conventional sinus surgery. Medical therapies are often successful, but for more than 20% of patients, they are not adequate.^7,8,9,10 In these cases, conventional sinus surgery is the patient's next hope for finding relief. However, conventional sinus surgery is a major operation that may require bone and tissue removal in order to open up blocked sinuses. For this or other clinical or personal reasons, over 900,000 patients that could benefit from surgery choose to forego it and live with their sinus condition.¹¹

The Balloon Sinuplasty™ System
Acclarent has developed the Balloon Sinuplasty™ system: a novel, endoscopic, catheter-based technology for sinusitis patients. This system is a family of proprietary products cleared by the FDA and currently being used in endoscopic surgical procedures throughout the U.S. and select countries worldwide. Balloon Sinuplasty™ products are specifically designed to navigate the tortuous sinus anatomy. The Sinus Balloon Catheter is gradually inflated to gently restructure the previously blocked nasal passage, maintaining the integrity of the sinus lining and restoring normal sinus drainage and function.

Learn more about Balloon Sinuplasty™ technology.

*Inflation adjusted

1. National Health Interview Survey, 2006.

2. US Census 2007.

3. Lusk, R., et al, Laryngoscope 2006; 116: 2099-2107.

4. Gliklich, R., et al, J Allergy Clin Immunol 1999; 113: 104-109.

5. Ray, N., et al, J Allergy Clin Immunol 1999; 103: 408-414.

6. Collins, J., Vital Health Stat 1997; 10: 1-89.

7. Hamilos, D., J Allergy Clin Immunol 2000; 106: 213-227.

8. Stankiewicz, J., et al, Am J Rhinol 2003; 17(3): 139-142.

9. Subramanian, H., et al, Am J Rhinol 2002; 16(6): 303-312.

10. Hessler, J., et al, Am J Rhinol 2007; 21(1): 10-18.

11. Acclarent, Inc. estimates based on National Health Interview Survey, 2006; US Census 2007; Lusk, R., et al, Laryngoscope 2006; 116: 2099-2107; Hamilos, D., J Allergy Clin Immunol 2000; 106: 213-227; Stankiewicz, J., et al, Am J Rhinol 2003; 17(3): 139-142; Subramanian, H., et al, Am J Rhinol 2002; 16(6): 303-312; Hessler, J., et al, Am J Rhinol 2007; 21(1): 10-18; Millenium Research Group, USENT08, 2008; Medtech Insight, A600, 2002; Medtech Insight, A566, 2005.